title: Etiology and management of Seborrheic dermatitis.
abstract: Seborrheic dermatitis (SD) is a common dermatological disorder that varies greatly in severity between individuals and with time. The etiology of this disease is poorly understood. Early investigators focused on the role of Malassezia (previously Pityrosporum) yeasts in the development of SD. Some researchers have hypothesized that there is an immunological component to SD and that this disease is caused by an altered immune response to Malassezia yeasts. However, other researchers view this condition as the result of hyperproliferation. Both antifungal and anti-inflammatory preparations have been used to treat SD effectively and safely. The wide range of antifungal formulations available (creams, shampoos, oral drugs) provides safe, effective and flexible treatment options for SD.
authors.affiliation: Department of Medicine, Sunnybrook and Women's College Health Science Center (Sunnybrook site), and University of Toronto, Toronto, Canada.
authors.forename: Aditya K
authors.initials: AK
authors.lastname: Gupta
authors.forename: S E
authors.initials: SE
authors.lastname: Madzia
authors.forename: Roma
authors.initials: R
authors.lastname: Batra
mesh_terms: D000293:Adolescent; D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002648:Child; D012628:Dermatitis, Seborrheic / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D000890:Anti-Infective Agents; D000935:Antifungal Agents; D003879:Dermatologic Agents